West Virginia University Logo

July 31, 2013

SAMHSA Prevention of Prescription Drug Abuse in the Workplace Listserv

Return to Listserv Archive Home

July 31, 2013  (PDF version)
Subscribe to the listserv.
Forward this issue to a colleague, friend, or family member.
Read archived issues.
Featured Article 
C.B. Dollar and B. Ray. 2013. "Adult Nonmedical Prescription Drug Use: An Examination of Bond Theory." Deviant Behavior 34(11). doi:10.1080/01639625.2013.800406.   
Using data from the 2010 National Survey on Drug Use and Health, this research examines the extent to which social bonds predict nonmedical prescription drug use among adults. Logistic regression analyses reveal that marital bonds are consistently associated with lower nonmedical use of various types of prescription drugs, controlling for other social and medical factors. Employment bonds are only associated with reduced nonmedical pain reliever use. The associations do not vary by gender.  
Read more:
Journal Articles
S.A. Maisto. 2013. "Neuroimaging Mechanisms of Change in Psychotherapy for Addictive Behaviors." Special issue, Psychology of Addictive Behaviors 27(2). Accessed online at http://psycnet.apa.org/index.cfm?fa=browsePA.volumes&jcode=adb
This issue of Psychology of Addictive Behaviors is devoted to National Institutes of Health-funded research aimed at integrating brain science and addiction treatment research. The authors address a range of addictive behaviors. Although none of the articles focus on prescription abuse, the papers listed below are relevant because they apply to addictions broadly.

  1. S.W. Feldstein Ewing and T. Chung. "Neuroimaging Mechanisms of Change in Psychotherapy for Addictive Behaviors: Emerging Translational Approaches that Bridge Biology and Behavior." Pages 329-335.
  2. J. Morgenstern, N.H. Naqvi, R. Debellis, and H.C. Breiter. "The Contributions of Cognitive Neuroscience and Neuroimaging to Understanding Mechanisms of Behavior Change in Addiction." Pages 336-350.
  3. K. Witkiewitz, M.K.B. Lustyk, and S. Bowen. "Retraining the Addicted Brain: A Review of Hypothesized Neurobiological Mechanisms of Mindfulness-Based Relapse Prevention." Pages 351-365.
  4. J.A. Brewer, H.M. Elwafi, J.H. Davis. "Craving to Quit: Psychological Models and Neurobiological Mechanisms of Mindfulness Training as Treatment for Addictions." Pages 366-379.
  5. R. Wetherill and S.F. Tapert. "Adolescent Brain Development, Substance Use, and Psychotherapeutic Change." Pages 393-402.
  6. C. Stanger, A.J. Budney, and W.K. Bickel. "A Developmental Perspective on Neuroeconomic Mechanisms of Contingency Management." Pages 403-415.
  7. M.T. Banich, A. De La Vega, J.R. Andrews-Hanna, K. Mackiewicz Seghete, Y. Du, E.D. and Claus. "Developmental Trends and Individual Differences in Brain Systems Involved in Intertemporal Choice During Adolescence." Pages 416-430.
  8. J. Jacobus,  R.E. Thayer, R.S. Trim, S. Bava, L.R. Frank, and S.F. Tapert. "White Matter Integrity, Substance Use, and Risk Taking in Adolescence." Pages 431-442.
  9. J.M. Houck, T.B. Moyers, and C.D. Tesche. "Through a Glass Darkly: Some Insights on Change Talk via Magnetoencephalography." Pages 489-500.
  10. T. Chung, S. Pajtek, and B.D. Clark. "White Matter Integrity as a Link in the Association Between Motivation to Abstain and Treatment Outcome in Adolescent Substance Users." Pages 533-542.
  11. R.E. Thayer and K.E. Hutchison. "Neuroimaging in Clinical Studies of Craving: Importance of Reward and Control Networks." Pages 543-546.

A.A. Bergman, M.S. Matthias, J.M. Coffing, and E.E. Krebs. 2013. "Contrasting Tensions Between Patients and PCPs in Chronic Pain Management: A Qualitative Study." Pain Medicine. doi:10.1111/pme.12172.
More research is needed to clarify how concerns and uncertainties about opioid therapy affect ways patients with chronic pain and primary care providers interact. The goal of this qualitative study was to develop a better understanding of their respective experiences, perceptions, and challenges when communicating about pain management.
Read more:
A. Golub and A.S. Bennett. 2013. "Prescription Opioid Initiation, Correlates, and Consequences Among a Sample of OEF/OIF Military Personnel." Substance Use & Misuse 48(10):811-20. doi:10.3109/10826084.2013.796988.    
This paper examines the pathways to prescription opioid (PO) misuse among a sample of U.S. veterans who recently returned from Iraq and Afghanistan to low-income, predominately minority sections of New York City. Recreational PO misuse was not common on deployment. Most PO misusers initiated use subsequent to PO use for pain management--an iatrogenic pathway. Veterans who misused POs were more likely to have other reintegration problems, including drug and alcohol use disorders, traumatic brain injury, unemployment, and homelessness.
D.B. Horton, D.M. Potter, and A.N. Mead. 2013. "A Translational Pharmacology Approach to Understanding the Predictive Value of Abuse Potential Assessments." Behavioural Pharmacology. doi:10.1097/FBP.0b013e3283644d2e.
Within the drug development industry, the assessment of abuse potential for novel molecules involves the generation and review of data from multiple sources, from in-vitro binding and functional assays to in-vivo nonclinical models in mammals, as well as collection of information from human studies. Researchers analyzed data from 100 small molecules to compare the predictive validity for drug scheduling status of models that typically contribute to the abuse potential assessment package. The predictive value of each model was then evaluated relative to the scheduling status of each drug in the United States. Recognizing that drug scheduling can be influenced by factors other than the pharmacology of the drug, the researchers also evaluated the predictive value of each assay for the outcome of the human subjective effects assessment. This approach provides an objective and statistical assessment of the predictive value of many models applied within the pharmaceutical industry to evaluate abuse risk.
Read more:
News and Reports
FDA Cautions Consumers on Illegal Diabetes Products 
July 24, 2013   
The Food and Drug Administration (FDA) recently issued letters to 15 companies warning the sale of their illegally marketed diabetes products violates federal law. The FDA requested a written response from the companies within 15 business days stating how they will correct the violations. Failure to comply may result in legal action.   
Read more: 
Using Pills to Fall Asleep at Night?
July 23, 2013   
Doctors wrote nearly 60 million prescriptions for Ambien, Lunesta, and other prescription sleep aids in 2012, according to IMS Health, a healthcare technology and information company. More than 19,000 people ended up in the emergency room (ER) in 2010 after taking Ambien or other drugs with the active ingredient zolpidem, according to a SAMHSA report. About three fourths of the ER patients were 45 or over, and one third were 65 or over.   
Read more: 
Deadly Epidemic: Prescription Drug Overdoses
July 24, 2013
More Americans now die from pain relievers than from heroin and cocaine combined. Since 2008, prescription drug-induced deaths have surpassed deaths from automobile accidents, according to the Centers for Disease Control and Prevention. In the past 11 years, deaths from overdose increased more than 400 percent among women, compared with a 265 percent rise among men.
Read more:
Commentary: My Prescription for the Prescription Drug Abuse Epidemic
The Partnership at Drugfree.org
July 23, 2013
Dr. Howard Mell says emergency physicians account for a very low percentage of all narcotics prescribed. The challenge for these doctors, he says, is to strike a balance between providing needed pain control and keeping the public safe. "For that reason, we employ a variety of techniques, from checking government databases to good old clinical judgment to separate those who need narcotic analgesia from those who may be seeking these drugs for purposes of abuse." To address the problem, Dr. Mell says access to primary care providers must be improved so patients with chronic conditions can be managed in a consistent manner. "We need to allow emergency physicians to refer chronic pain patients to their primary care providers without prescriptions for narcotic medications and without repercussions from the dreaded 'surveys,'" he notes. "Lastly, we need to improve access to mental health and addiction recovery services, so that we can provide addicted patients the assistance they really need instead of the drugs they want."
Read more:
Proposed Law Calls for Commission to Focus on Prescription Drug Abuse Efforts 
National Association of Boards of Pharmacy
July 24, 2013
A bill calling for a 30-member commission to coordinate law enforcement and health agency efforts combating prescription drug abuse was introduced in the U.S. Senate. The commission would include representatives from the Drug Enforcement Administration, Food and Drug Administration, and Office of National Drug Control Policy, as well as patient advocacy groups, healthcare experts, and public policy experts. The proposed Combating Prescription Drug Abuse Act would call on the commission to investigate and report on use of prescription drug monitoring programs, efforts to fight pill mills and illegal Internet drug sellers, and facilitation of proper disposal of prescription drugs, among other issues.
Read more:
PCMA: 'Safe Rx Initiative' Offers Policy Solutions to Curb Prescription Drug Abuse and Fraud
PR Newswire
July 24, 2013
The Pharmaceutical Care Management Association released a set of policy solutions, "The Safe Rx Initiative," to reduce prescription drug abuse and fraud in Medicare and the commercial sector by making it more difficult for drug seekers to obtain fraudulent prescriptions.
Read more:
Other State and Local News
RX Trafficking Ring Controlled Brooklyn Medical Practices: Nearly $3.4 Million in Pills Diverted
Drug Enforcement Agency
July 17, 2013
Drug Enforcement Administration and New York City police agents arrested five members of a prescription drug trafficking ring that illegally collected and distributed more than $3.4 million in oxycodone and other prescription drugs through medical offices they controlled in Brooklyn. "These arrests highlight the growing problem of drug diversion in America," said Tom O'Donnell, Special Agent in Charge at the Department of Health and Human Services (HHS) Office of the Inspector General, New York region. "HHS will continue to work with our law enforcement partners to combat prescription drug fraud at all levels. We must protect federal health programs from criminals who abuse the system to fuel this epidemic."
Read more:
12 Charged in Alleged Prescription Drug Ring 
CBS Pittsburgh
July 23, 2013
Twelve people were charged in an alleged prescription drug ring in Pittsburgh, Pennsylvania. Accused of maintaining an elaborate scheme to obtain and sell pain medication, some were charged with narcotics violations and witness intimidation.
Read more:
Nose Spray Narcan Reverses Overdoses in Mass. Town at High Rate
July 21, 2013
More than 500 people in Massachusetts die each year from accidental opioid overdoses--three fourths from pain relievers, according to Massachusetts Department of Health data. Since the Narcan pilot program began in late 2010, Quincy police have used the nose spray 179 times and reversed overdoses 170 times--a 95 percent success rate. Narcan only works with opioids.
Read more:
More Education Needed on Dangers of Prescription Drugs
July 24, 2013
Prescription drug deaths nearly doubled in Colorado from 2000 to 2010, climbing from 228 to 414, according to the Denver County Sheriff's Office. "Narcotic pain relievers are causing a great deal of dependence and abuse," Team Fort Collins Executive Director Ashley Kasprzak said. "Individuals are falling into this without being predisposed to drug use."
Read more:
Arkansas Health Officials Focus on Reducing Prescription Drug Overdoses
The Partnership at Drugfree.org
July 24, 2013
Arkansas is focusing on reducing prescription drug overdoses, which account for about one death daily in the state. Its prescription drug take-back program has collected more than 32 tons of medication from homes.
Read more:
Drug Monitoring Program Producing Results Six Weeks into Its Launch
Wisconsin Public Radio News
July 24, 2013
The Wisconsin prescription drug monitoring program (PDMP) run by the Department of Safety and Professional Services determines if people are getting pain relievers from different doctors. Dr. Matt Horning, a family medicine practitioner at the Chequamegon Clinic in Ashland, thinks the number of people dying from prescription drug abuse will drop. He says the PDMP is working: "It helps you keep patients safe and not add to this problem of addiction and dependency and diversion of prescription drugs for non-medical uses."
Read more:
Billings Woman Pleads Guilty to Stealing Prescription Drugs
July 23, 2013
A 32-year-old Billings, Montana, woman has pleaded guilty to stealing prescription pain medicine from the pharmacy where she worked. Prosecutors say Ms. Buckland told a Drug Enforcement Administration agent she was stealing pills and using about 100 of them per day. Store records indicated about 18,000 hydrocodone and oxycodone pills were taken from the pharmacy over a 6-month period.
Read more:
Other Resources
Substance Use in Older Adults: Screening and Treatment Intervention Strategies
Addiction Technology Transfer Center Network
Accessed July 29, 2013
This 3-hour self-paced online course reviews alcohol and prescription medication use among older adults, and highlights the need for routine screening, assessment, and specialized interventions. The Addiction Technology Transfer Center Network is funded by SAMHSA.
Read more:
Responding to Prescription Drug Abuse
June 24, 2013
This video features a Webinar on the prescription drug abuse epidemic and how we can respond. Lead speaker Ted Miller, Ph.D., Director of SAMHSA's Preventing Prescription Abuse in the Workplace Technical Assistance Center, discusses abuse statistics, trends, and the resources and evidence-based programs available for communities and workplaces to address the problem. Dr. Miller also describes screening and early intervention, treatment, and harm reduction strategies.
Read more:
Grant Announcements
Collaborative Research on Addiction at NIH (CRAN)
National Institutes of Health
July 17, 2013
The National Institute on Drug Abuse (NIDA), National Cancer Institute (NCI), and National Institute on Alcohol Abuse and Alcoholism (NIAAA) released two new funding opportunities to promote the goals of Collaborative Research on Addiction at the National Institutes of Health (CRAN). The initiative provides a strong collaborative framework for NIDA, NCI, and NIAAA to pool resources and expertise, creating synergies in addiction science, addressing new research opportunities, and meeting public health needs. CRAN will solicit administrative supplements or revision applications to expand the scope of currently funded projects to be more cross-cutting and inclusive. Applications open August 24, 2013, and are due September 24, 2013.
Read more:
Prescription Drug Abuse Prevention Recognition Program
United States Conference of Mayors
Accessed July 26, 2013
The Prescription Drug Abuse Prevention Recognition Program is part of Safeguard My Meds, an educational program established by the National Community Pharmacists Association and Purdue Pharma LP to increase awareness about safe storage and disposal of prescription medicine. The goal of the awards program is to honor outstanding educational, public awareness, and other initiatives that address prescription drug misuse and abuse in U.S. cities. Applications are due August 30, 2013.
Read more:
Save the Date
DEA's National Take-Back Initiative
October 26, 2013
Read more:
Upcoming Conferences and Workshops
Pharmacy Diversion Awareness Conference
August 3 and 4: Baton Rouge, Louisiana
August 16 and 17: San Diego, California
August 18 and 19: San Jose, California
September 21 and 22: Boston, Massachusetts
The Generation Rx University Conference for Prescription Drug Abuse Prevention and Recovery
August 7-8, 2013
Columbus, Ohio
National Conference on Addiction Disorders 2013
September 21-25, 2013
Anaheim, California
Harold Rogers Prescription Drug Monitoring Program National Meeting
September 25-27, 2013
Washington, District of Columbia
2013 National Safety Council Congress and Expo
Congress: September 28-October 4, 2013
Expo: September 30-October 2, 2013
Chicago, Illinois
4th Annual Executive Forum on Creating a Culture of Health and Wellness   
October 7-8, 2013
Chicago, Illinois
2013 American Association for Treatment of Opioid Dependence Conference
November 9-13, 2013
Philadelphia, Pennsylvania
11th Annual World Health Care Congress  
April 7-9, 2014
National Harbor, Maryland
Please e-mail Rekaya Gibson at rgibson@pire.org with questions or comments about the SAMHSA Prevention of Prescription Drug Abuse in the Workplace Listserv.  

About PAW and the Listserv
The PAW TA Center addresses prescription drug abuse--a growing public health problem with increasing burdens on workers, workplaces, and our economy. Prescription drug abuse affects workplace productivity and increases employee absenteeism, employee presenteeism, and workers' compensation claims. On a wider scale, overdose deaths linked to prescription opioids tripled from 1999 to 2006, and prescription drug abuse killed more Americans in 2009 than died that year in auto crashes.
Send your request for PAW technical assistance to PAW-TA@pire.org or contact Rekaya Gibson at 504.261.8107 or Deborah Galvin at 240.276.2721. Requests are subject to SAMHSA approval. You will be notified of the status of your request.
We aim to conduct systematic and inclusive searches of professional journals, leading newspapers and magazines, and federal websites, as well as contributions from listserv subscribers (please e-mail suggestions to rgibson@pire.org). We will send links to articles along with brief descriptions of those articles. As we develop the listserv, however, we hope to add commentary and invite feedback from subscribers. Our goal is to expand the listserv to become a widely used and recognized source of the most current and authoritative information on prescription drug abuse--especially in workplaces.
You currently have a free listserv subscription. If you want to stop your subscription, please click here.
The "SAMHSA Prevention of Prescription Drug Abuse in the Workplace Listserv" is a service provided by the SAMHSA Preventing Prescription Abuse in the Workplace Technical Assistance Center (PAW) to keep the field abreast of recent news and journal articles to assist in forming policy, research, and programs to reduce prescription drug misuse or abuse. Please note, the materials listed are not reflective of SAMHSA's or PAW's viewpoints or opinions and are not assessed for validity, reliability, or quality. The "SAMHSA Prevention of Prescription Drug Abuse in the Workplace Listserv" should not be considered an endorsement of the findings. Readers are cautioned not to act on the results of single studies, but rather to seek bodies of evidence. Copyright considerations prevent PAW from providing full-text journal articles.
The Injury Control Research Center at West Virginia University (WVU-ICRC) archives past Listserv issues at http://www.hsc.wvu.edu/icrc/Pages/SAMHSA-Prevention-of-Prescription-Drug-Abuse-in-th. The partnership efforts of WVU-ICRC are supported by Grant Number 1 R49 CE002109 from the Centers for Disease Control and Prevention (CDC). The contents of the Listserv archive are solely the responsibility of the authors and do not represent the official views of CDC or SAMHSA.

Return to Listserv Archive Home